Zehra Tan Develi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zehra Tan Develi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ali Bülent Cengiz
Department of Pediatric Infectious Disease, Faculty of Medicine, Hacettepe University, Ankara, Türkiye
1 shared publication - Alpaslan Alp
Department of Medical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkiye
1 shared publication - Berivan Onel
Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Türkiye
1 shared publication - Kubra Aykac
Department of Pediatric Infectious Disease, Faculty of Medicine, Hacettepe University, Ankara, Türkiye
1 shared publication - Osman Oguz Demir
Department of Pediatric Infectious Diseases Hacettepe University Faculty of Medicine Ankara Türkiye
1 shared publication - Yasemin Ozsurekci
Department of Pediatric Infectious Diseases, Hacettepe University, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 29 December 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (2) , 162-167
Clinical Features and Outcomes of Severe Pneumonia in Pediatric Human Metapneumovirus Infections
Objective: Human metapneumovirus (hMPV) is a significant agent of respiratory infections in pediatric populations. Despite its global prevalence, the epidemiological characteristics and clinical burden of hMPV infections remain insufficiently recognized. This study aimed to evalu ate the clinical features and outcomes of severe pneumonia among children hospitalized with hMPV infection. Materials and Methods: This retrospective study analyzed pediatric patients diagnosed with hMPV infection at Hacettepe University İhsan Doğramacı Children’s Hospital between January 2018 and December 2024. Demographic, clinical, and laboratory data were systematically reviewed to identify factors associated with severe pneumonia. Results: A total of 116 children with hMPV infection were included, of whom 17.2% (n = 20) devel oped severe pneumonia requiring respiratory support. Notably, 85% (n = 17) of these severe cases occurred in children under 5 years of age, and 90% (n = 18) had underlying chronic medi cal conditions. In cases of non-severe pneumonia, hMPV monoinfection was identified in 74.8% (n = 56) of patients, while 25.2% (n = 19) had coinfections, most commonly involving rhinovirus (14.7%, n = 17). Conversely, among severe pneumonia cases, hMPV monoinfection was predom inant (90%, n = 18), with coinfections detected in only 10% (n = 2). A substantial increase in hospi talization rates was observed in 2024 (36%), potentially indicating an evolving disease severity. Additionally, 1 infection-related mortality (3.1%) was recorded in an older pediatric patient. Conclusion: Severe pneumonia in this single-center series was mainly linked to hMPV monoin fection, with hospitalizations rising in 2024. These findings underscore the clinical impact of hMPV and the need for strengthened surveillance and timely diagnostics, while informing pre ventive strategies, including future vaccines/therapeutics.
- 29 December 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (2) , 162-167
Open AccessClinical Features and Outcomes of Severe Pneumonia in Pediatric Human Metapneumovirus Infections
Objective: Human metapneumovirus (hMPV) is a significant agent of respiratory infections in pediatric populations. Despite its global prevalence, the epidemiological characteristics and clinical burden of hMPV infections remain insufficiently recognized. This study aimed to evalu ate the clinical features and outcomes of severe pneumonia among children hospitalized with hMPV infection. Materials and Methods: This retrospective study analyzed pediatric patients diagnosed with hMPV infection at Hacettepe University İhsan Doğramacı Children’s Hospital between January 2018 and December 2024. Demographic, clinical, and laboratory data were systematically reviewed to identify factors associated with severe pneumonia. Results: A total of 116 children with hMPV infection were included, of whom 17.2% (n = 20) devel oped severe pneumonia requiring respiratory support. Notably, 85% (n = 17) of these severe cases occurred in children under 5 years of age, and 90% (n = 18) had underlying chronic medi cal conditions. In cases of non-severe pneumonia, hMPV monoinfection was identified in 74.8% (n = 56) of patients, while 25.2% (n = 19) had coinfections, most commonly involving rhinovirus (14.7%, n = 17). Conversely, among severe pneumonia cases, hMPV monoinfection was predom inant (90%, n = 18), with coinfections detected in only 10% (n = 2). A substantial increase in hospi talization rates was observed in 2024 (36%), potentially indicating an evolving disease severity. Additionally, 1 infection-related mortality (3.1%) was recorded in an older pediatric patient. Conclusion: Severe pneumonia in this single-center series was mainly linked to hMPV monoin fection, with hospitalizations rising in 2024. These findings underscore the clinical impact of hMPV and the need for strengthened surveillance and timely diagnostics, while informing pre ventive strategies, including future vaccines/therapeutics.